References
- Gaier ED, Boudreault K, Nakata I, Janessian M, Skidd P, DelBono E, Allen KF, Pasquale LR, Place E, Cestari DM, et al. Diagnostic genetic testing for patients with bilateral optic neuropathy and comparison of clinical features according to OPA1 mutation status. Mol Vis. 2017;23:548–60. Cited in PubMed; PMID:28848318.
- Lenaers G, Hamel C, Delettre C, Amati-Bonneau P, Procaccio V, Bonneau D, Reynier P, Milea D. Dominant optic atrophy. Orphanet J Rare Dis. 2012;7:46. Cited in PubMed; PMID:22776096. doi:10.1186/1750-1172-7-46.
- Neuhann T, Rautenstrauss B. Genetic and phenotypic variability of optic neuropathies. Expert Rev Neurother. 2013;13(4):357–67. Cited in PubMed; PMID: 23545052. doi:10.1586/ern.13.19.
- Milea D, Amati-Bonneau P, Reynier P, Bonneau D. Genetically determined optic neuropathies. Curr Opin Neurol. 2010;23(1):24–28. Cited in PubMed; PMID:19915464. doi:10.1097/WCO.0b013e3283347b27.
- Srivastava S, Gubbels CS, Dies K, Fulton A, Yu T, Sahin M. Increased survival and partly preserved cognition in a patient with ACO2-related disease secondary to a novel variant. J Child Neurol. 2017;32(9):840–45. Cited in PubMed; PMID:28545339. doi:10.1177/0883073817711527.
- Ferre M, Bonneau D, Milea D, Chevrollier A, Verny C, Dollfus H, Ayuso C, Defoort S, Vignal C, Zanlonghi X, et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat. 2009;30(7):E692–705. Cited in PubMed; PMID:19319978. doi:10.1002/humu.21025.
- Angebault C, Guichet PO, Talmat-Amar Y, Charif M, Gerber S, Fares-Taie L, Gueguen N, Halloy F, Moore D, Amati-Bonneau P, et al. Recessive mutations in RTN4IP1 cause isolated and syndromic optic neuropathies. Am J Hum Genet. 2015;97(5):754–60. Cited in PubMed; PMID:26593267. doi:10.1016/j.ajhg.2015.09.012.
- Hartmann B, Wai T, Hu H, MacVicar T, Musante L, Fischer-Zirnsak B, Stenzel W, Graf R, van den Heuvel L, Ropers HH, et al. Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation. Elife. 2016;5. Cited in PubMed; PMID:27495975. doi:10.7554/eLife.16078.
- Metodiev MD, Gerber S, Hubert L, Delahodde A, Chretien D, Gerard X, Amati-Bonneau P, Giacomotto M, Boddaert N, Kaminska A, et al. Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy. J Med Genet. 2014;51(12):834–38. Cited in PubMed; PMID:25351951. doi:10.1136/jmedgenet-2014-102532.
- Sadat R, Barca E, Masand R, Donti TR, Naini A, De Vivo DC, DiMauro S, Hanchard NA, Graham BH. Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency. Mol Genet Metab. 2016;118(1):28–34. Cited in PubMed; PMID:26992325. doi:10.1016/j.ymgme.2016.03.004.
- Spiegel R, Pines O, Ta-Shma A, Burak E, Shaag A, Halvardson J, Edvardson S, Mahajna M, Zenvirt S, Saada A, et al. Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2. Am J Hum Genet. 2012;90(3):518–23. Cited in PubMed; PMID:22405087. doi:10.1016/j.ajhg.2012.01.009.
- Chun BY, Rizzo JF 3rd. Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation. Curr Opin Ophthalmol. 2016;27(6):475–80. Cited in PubMed; PMID:27585216. doi:10.1097/ICU.0000000000000314.